Trial intelligence / Profile preview

Bryophyllum pinnatum vs. Nifedipine for Preterm Contractions

NCT00391339Phase 3Unknown

Sponsor
Weleda
Start
Nov 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of Bryophyllum pinnatum in Preterm labor (PTL) (2 arms), sponsored by Weleda. Primary endpoint: Efficacy of tocolysis. Status: unknown.

02

Drugs

Bryophyllum pinnatum
03

Conditions

Preterm labor (PTL)

Beyond the preview

Go deeper on NCT00391339.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00391339.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call